RELATIONSHIP BETWEEN VITAMIN D SERUM [25(OH)D] AND MORBUS HANSEN: A SYSTEMATIC REVIEW

Oktaviani Eka Puspasari

doi:10.47353/bj.v5i12.94

Authors

Oktaviani Eka Puspasari Universitas Udayana-RSUP Prof Ngoerah, Denpasar, Bali

DOI:

https://doi.org/10.47353/bj.v5i12.94

Abstract

Morbus Hansen (MH) is a chronic granulomatous infection caused by Mycobacterium leprae, characterized by anesthesia, peripheral nerve thickening, and the presence of acid-fast bacilli (AFB) on bacteriological examination. Vitamin D is known to play an important immunomodulatory role in the immune response to mycobacterial infections. This study aims to review existing research on the relationship between serum levels of 25-hydroxyvitamin D [25(OH)D] and Morbus Hansen. A critical analysis was performed on scientific articles retrieved from PubMed, Google Scholar, and ScienceDirect databases, covering publications from the past 10 years that discussed vitamin D levels in patients with Morbus Hansen. Five articles meeting the inclusion criteria for this study. Serum vitamin D levels in Morbus Hansen patients were lower compared to healthy controls and showed a significant association with the clinical type of MH. Patients with the paucibacillary type had higher vitamin D levels than those with the multibacillary type. Vitamin D plays a role in the immune response against Mycobacterium leprae, and vitamin D deficiency may increase the risk and severity of the disease

Downloads

Download data is not yet available.

References

Al-Jaberi, F. A., Crone, C. G., Lindenstrøm, T., Arildsen, N. S., Lindeløv, E. S., Aagaard, L., … Geisler, C. (2022). Reduced vitamin D-induced cathelicidin production and killing of Mycobacterium tuberculosis in macrophages from a patient with a non-functional vitamin D receptor: A case report. Frontiers in Immunology, 13, 1038960.

Amin, S., Djawad, K., & Ilyas, F. (2024). Analysis of vitamin D receptor levels in serum of leprosy patients of multibacillary type, erythema nodosum leprosum and normal people. Journal of Pakistan Association of Dermatologists, 34(3).

Athanassiou, L., Mavragani, C. P., & Koutsilieris, M. (2022). The immunomodulatory properties of vitamin D. Mediterranean Journal of Rheumatology, 33(1), 7–13.

Cao, Y., Wang, X., Liu, P., Su, Y., Yu, H., & Du, J. (2022). Vitamin D and the risk of latent tuberculosis infection: A systematic review and meta-analysis. BMC Pulmonary Medicine, 22(1), 39.

Darus, N. I. M., Lubis, R. D., & Jusuf, N. K. (2019). Analysis of serum vitamin D level in leprosy patients. Bali Medical Journal, 8(3).

Dennison, C. L., de Oliveira, L. B., Fraga, L. A. D. O., Lima, R. S., Ferreira, J. A., Clennon, J. A., & Fairley, J. K. (2021). Mycobacterium leprae-helminth co-infections and vitamin D deficiency as potential risk factors for leprosy: A case-control study in south-eastern Brazil. International Journal of Infectious Diseases, 105, 261–266.

Garg, V., Garg, R. K., Rizvi, I., et al. (2020). Vitamins A, C, D, E and B12 levels in leprosy: A case control study. Indian Journal of Leprosy, 92, 81–88.

Greiller, C. L., & Martineau, A. R. (2015). Modulation of the immune response to respiratory viruses by vitamin D. Nutrients, 7(6), 4240–4270.

Halim, P. A., Sirait, S. P., Miranda, E., Ariani, Y., Indriatmi, W., & Thio, H. B. (2025). Comparison of serum vitamin D level and vitamin D receptor gene FokI polymorphism in leprosy patients with and without trophic ulcers: Protocol for a case-control study. F1000Research, 14, 57.

Hilma, R. F., Widaty, S., Marissa, M., & Ilyas, M. (2023). Association between serum level of vitamin D (25-hydroxyvitamin D) and plasma level of vitamin D receptor with bacteriological index in leprosy patients. Dermatology Reports, 15(4), 9705.

Idris, F., & Mellaratna, W. P. (2023). Morbus Hansen. Diponegoro Medical Journal, 12(5), 330–335.

Ismailova, A., & White, J. H. (2022). Vitamin D, infections and immunity. Reviews in Endocrine and Metabolic Disorders, 23(2), 265–277.

Jaimni, V., Shasty, B. A., Madhyastha, S. P., Shetty, G. V., Acharya, R. V., Bekur, R., & Doddamani, A. (2021). Association of vitamin D deficiency and newly diagnosed pulmonary tuberculosis. Pulmonary Medicine, 2021, 5285841.

Kimberly, K., Ferina, S. A., & Esti, P. K. (2024). Immunomodulators in leprosy: A narrative review. Journal of General-Procedural Dermatology & Venereology Indonesia, 8(1), 10.

Martins, B. L., Perico, J., Bertoluci, D. F., Barbosa, A. S., Rosa, P. S., Nogueira, M. R. S., … Latini, A. C. (2024). Iron and vitamin D intake on a diet are able to modify the in vitro immune response to Mycobacterium leprae. Memórias do Instituto Oswaldo Cruz, 119, e230178.

Ministry of Health of the Republic of Indonesia. (2022). Annual report leprosy control program 2022 (pp. 9–38).

Orujyan, D., Narinyan, W., Rangarajan, S., Rangchaikul, P., Prasad, C., Saviola, B., & Venketaraman, V. (2022). Protective efficacy of BCG vaccine against Mycobacterium leprae and non-tuberculous mycobacterial infections. Vaccines, 10(3), 390.

Osyntseva, A. (2025). The potential of vitamin D in tuberculosis pharmacotherapy: Retrospective, marketing review, and application prospects. SSP Modern Pharmacy and Medicine, 5(1), 1–15.

Paz, J. L. P., Silvestre, M. D. P. S. C. A., Moura, L. S., Furlaneto, I. P., Rodrigues, Y. C., Lima, K. V. B., & Lima, L. N. G. C. (2021). Association of the polymorphism of the vitamin D receptor gene (VDR) with the risk of leprosy in the Brazilian Amazon. Bioscience Reports, 41(7), BSR20204102.

Toruan, T. L., Devi, M., Theodorus, & Rivai, A. M. (2021). Relationship between 25-hydroxy vitamin D levels and type of Morbus Hansen. Bioscientia Medicina: Journal of Biomedicine and Translational Research, 5(9), 883–889.

van Hooij, A., & Geluk, A. (2021). In search of biomarkers for leprosy by unraveling the host immune response to Mycobacterium leprae. Immunological Reviews, 301(1), 175–192.

Yang, Y., Deng, J., Liu, P., He, J., Tan, J., Yu, B., Bai, Y., Luo, F., Xu, J., & Zhang, Z. (2025). Vitamin D inhibits apoptosis in THP-1 cells infected with Mycobacterium tuberculosis through TNF signaling pathway. Frontiers in Immunology, 16, 1525922.

Yulianto, R., & Gunawan, E. A. (2024). Prevalence, risk factors and management of Morbus Hansen in primary health care in low income countries: A comprehensive systematic review. The International Journal of Medical Science and Health Research, 1(2), 243–257.

Zavala, K., Gottlieb, C. A., Teles, R. M., Adams, J. S., Hewison, M., Modlin, R. L., & Liu, P. T. (2018). Intrinsic activation of the vitamin D antimicrobial pathway by M. leprae infection is inhibited by type I IFN. PLoS Neglected Tropical Diseases, 12(10), e0006815.